Literature DB >> 12453429

Induction of protein translation by ADAR1 within living cell nuclei is not dependent on RNA editing.

Alan Herbert1, Stefan Wagner, Jeffrey A Nickerson.   

Abstract

Translation of mRNA is usually cytoplasmic. We report that the RNA editing enzyme ADAR1, which catalyzes the deamination of adenosine to inosine in double-stranded RNA substrates, induces translation within the nucleus, possibly at the surface of the nucleolus. This activity does not depend on RNA editing. Two regions within ADAR1 are defined that act independently of each other to induce translation: the first includes the double-stranded RNA binding domains (DRBMs) of ADAR1 while the second maps to the C-terminal portion of the catalytic domain. Point mutations within each domain are identified that reduce nuclear translation; those in the DRBM region are also known to diminish RNA binding. This report adds to the growing functionality ascribed to the nucleus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12453429     DOI: 10.1016/s1097-2765(02)00737-2

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  12 in total

1.  SUMO-1 modification alters ADAR1 editing activity.

Authors:  Joana M P Desterro; Liam P Keegan; Ellis Jaffray; Ron T Hay; Mary A O'Connell; Maria Carmo-Fonseca
Journal:  Mol Biol Cell       Date:  2005-08-24       Impact factor: 4.138

2.  Dimerization of ADAR2 is mediated by the double-stranded RNA binding domain.

Authors:  Hanne Poulsen; Rasmus Jorgensen; Anders Heding; Finn C Nielsen; Bjarne Bonven; Jan Egebjerg
Journal:  RNA       Date:  2006-05-08       Impact factor: 4.942

3.  Reovirus-mediated induction of ADAR1 (p150) minimally alters RNA editing patterns in discrete brain regions.

Authors:  Jennifer L Hood; Michael V Morabito; Charles R Martinez; James A Gilbert; Elizabeth A Ferrick; Gregory D Ayers; James D Chappell; Terence S Dermody; Ronald B Emeson
Journal:  Mol Cell Neurosci       Date:  2014-06-04       Impact factor: 4.314

4.  ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia.

Authors:  Qingfei Jiang; Leslie A Crews; Christian L Barrett; Hye-Jung Chun; Angela C Court; Jane M Isquith; Maria A Zipeto; Daniel J Goff; Mark Minden; Anil Sadarangani; Jessica M Rusert; Kim-Hien T Dao; Sheldon R Morris; Lawrence S B Goldstein; Marco A Marra; Kelly A Frazer; Catriona H M Jamieson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-28       Impact factor: 11.205

5.  Visualizing adenosine-to-inosine RNA editing in the Drosophila nervous system.

Authors:  James E C Jepson; Yiannis A Savva; Kyle A Jay; Robert A Reenan
Journal:  Nat Methods       Date:  2011-12-25       Impact factor: 28.547

6.  ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing.

Authors:  Yongzhan Nie; Li Ding; Peter N Kao; Robert Braun; Jing-Hua Yang
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

7.  ADAR1 ablation decreases bone mass by impairing osteoblast function in mice.

Authors:  Shibing Yu; Rohit Sharma; Daibang Nie; Hongli Jiao; Hee-Jeong Im; Yumei Lai; Zhongfang Zhao; Ke Zhu; Jie Fan; Di Chen; Qingde Wang; Guozhi Xiao
Journal:  Gene       Date:  2012-10-31       Impact factor: 3.688

8.  Prognostic significance of copy-number alterations in multiple myeloma.

Authors:  Hervé Avet-Loiseau; Cheng Li; Florence Magrangeas; Wilfried Gouraud; Catherine Charbonnel; Jean-Luc Harousseau; Michel Attal; Gerald Marit; Claire Mathiot; Thierry Facon; Philippe Moreau; Kenneth C Anderson; Loïc Campion; Nikhil C Munshi; Stéphane Minvielle
Journal:  J Clin Oncol       Date:  2009-08-17       Impact factor: 44.544

9.  Distinct in vivo roles for double-stranded RNA-binding domains of the Xenopus RNA-editing enzyme ADAR1 in chromosomal targeting.

Authors:  Michael Doyle; Michael F Jantsch
Journal:  J Cell Biol       Date:  2003-04-28       Impact factor: 10.539

10.  Regulation of mRNA export by the PI3 kinase/AKT signal transduction pathway.

Authors:  Alexandre Jose Christino Quaresma; Rachel Sievert; Jeffrey A Nickerson
Journal:  Mol Biol Cell       Date:  2013-02-20       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.